GlassScriptPhysician profile
Wendell J Scott
NPI 1710077151
$42,231.64
in general payments reported to CMS, 2019-2025
10 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,631 · 2020: $14K · 2021: $9,980 · 2022: $3,310 · 2023: $2,376 · 2024: $2,533 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,050 · Food and Beverage: $1,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,050.00 |
| Food and Beverage | $1,153.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $41,293.57 | 2019-2025 | Tecnis Iol, Compact Intuitiv, Healon Duet Pro |
| Glaukos Corporation | $228.62 | 2024 | Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Carl Zeiss Meditec, INC. | $188.58 | 2020-2021 | |
| Sight Sciences, INC. | $105.71 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $105.60 | 2019-2023 | Hydrus Microstent |
| Rxsight INC | $104.42 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Ivantis, INC | $92.36 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $46.19 | 2021 | |
| Abbvie INC. | $36.11 | 2024 | |
| Sun Pharmaceutical Industries INC. | $30.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendell Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.